iShares U.S. Healthcare ETF (IYH)

The immediate outlook is aggressively bullish, driven by a massive surge in call buying at lower strikes that signals a speculative bid for a rapid recovery toward the 75 level. This sentiment is reinforced by the complete absence of put volume, leaving the floor open for upside momentum. However, the long-term picture remains mixed; while the asset has delivered an exceptional 88% gain over the last nine years, the most recent annual performance was a sharp -10.92% decline. This single year of weakness prevents a top-tier 'exceptional buy' rating, capping the long-term score at a solid 3 despite the strong historical compounder. The dividend yield of roughly 1.1% is modest, offering income but not serving as a primary investment driver. Ultimately, the trade here is a high-conviction momentum play on a sector leader that has recently corrected but retains a fortress balance sheet and dominant market position.